<DOC>
	<DOCNO>NCT00644254</DOCNO>
	<brief_summary>Extracapsular lymph node involvement ( ECLNI ) identify pathological variable associate bad outcome esophageal , gastric colorectal cancer . No study far study prognostic impact ductal pancreatic adenocarcinoma ( DPAC ) . The goal investigator determine prognostic value ECLNI prospective consecutive series 145 patient DPAC , underwent resection primary tumor 1998 2005 .</brief_summary>
	<brief_title>The Prognostic Impact Extracapsular Lymph Node Involvement Ductal Pancreatic Adenocarcinoma</brief_title>
	<detailed_description>Presence extent extracapsular lymph node involvement ( ECLNI ) score review original pathological slide . ECLNI define metastatic adenocarcinoma extend nodal capsule perinodal fatty tissue . Observers : 1 experience board-certified GI pathologist , blind follow-up result . Follow-up data obtain review patient chart telephone survey patient 's GP/gastroenterologist November 2007 . Statistical analysis : - Common closing date : 1/11/2007 - Kaplan-Meier survival analysis ( Log-Rank , Wilcoxon ) - Cox logistic regression ( uni/multivariate )</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>DPAC Primary resection Positive section margin non DPAC , tumor Postoperative mortality Neoadjuvant chemo/radiotherapy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Prognosis</keyword>
	<keyword>Extracapsular lymph node involvement</keyword>
</DOC>